Can leuprolide be used to optimize implantation and pregnancy outcomes in frozen embryo transfer cycles, and what evidence supports its use in these scenarios?
Gaurav ChauhanContributor
IVF Questions & Answers
Sign Up to our social questions and Answers Engine to ask questions, answer people’s questions, and connect with other people.
Please briefly explain why you feel this question should be reported.
Please briefly explain why you feel this answer should be reported.
Please briefly explain why you feel this user should be reported.
Can leuprolide be used to optimize implantation and pregnancy outcomes in frozen embryo transfer cycles, and what evidence supports its use in these scenarios?
Leuprolide, a GnRH agonist, is sometimes used in frozen embryo transfer (FET) to enhance implantation. Studies indicate it can improve outcomes, particularly in patients with implantation failure history.
Leuprolide can enhance implantation and pregnancy in frozen embryo transfers. Research indicates it improves endometrial receptivity by ensuring better hormonal synchronization.
Leuprolide use in frozen embryo transfers is supported by its ability to regulate hormone levels, increasing the chances of successful pregnancy outcomes.